Results of simulation of performance indicators for the oncological service when introducing innovative technologies for treatment of stage IV lung cancer
| Autor: | O. V. Zelenova, N. A. Golubev, V. M. Danilov, S. A. Sterlikov, S. I. Аbramov, Yu. V. Mikhaylova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Chemotherapy Bronchus RC705-779 business.industry medicine.medical_treatment Cancer Tumor cells General Medicine respiratory system effects of malignant tumors chemotherapy improvement medicine.disease lung cancer lung cancer chemotherapy Diseases of the respiratory system medicine.anatomical_structure Internal medicine Case fatality rate medicine Performance indicator Stage iv Lung cancer business |
| Zdroj: | Tuberkulez i Bolezni Lëgkih, Vol 98, Iss 4, Pp 15-23 (2020) |
| ISSN: | 2542-1506 2075-1230 |
| Popis: | Malignant tumors of the trachea, bronchi, lungs represent a serious medical and social problem. Most cases of cancer of the trachea, bronchus, and lung are detected at stage IV, and therefore, to improve the survival of patients, a new treatment strategy is proposed based on modern data on mutagenesis and receptor status of tumor cells, which has a personalized approach for each specific case. To make managerial decisions about the introduction of innovative drugs, a forecast of expected results is required which should be improved indicators of the State Program On Healthcare Development. It has been found out that the transition to a new strategy for lung cancer chemotherapy will reduce mortality from malignant tumors by 1.2-0.7%, including lung cancer by 3.9%, as well as one-year case fatality by 3% for all malignant tumors, including 15% for lung cancer. At the same time, within 5 years after the introduction of the new strategy for lung cancer treatment, the indicator reflecting the proportion of patients with malignant tumors registered for 5 years or more is expected to decrease, which is related to specific parameters of the calculation method.The authors state that they have no conflict of interests. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|